Cargando…

SGLT2 Inhibitor—Dapagliflozin Attenuates Diabetes-Induced Renal Injury by Regulating Inflammation through a CYP4A/20-HETE Signaling Mechanism

Diabetic kidney disease (DKD) is a serious complication of diabetes, affecting millions of people worldwide. Inflammation and oxidative stress are key contributors to the development and progression of DKD, making them potential targets for therapeutic interventions. Sodium-glucose cotransporter 2 i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dia, Batoul, Alkhansa, Sahar, Njeim, Rachel, Al Moussawi, Sarah, Farhat, Theresa, Haddad, Antony, Riachi, Mansour E., Nawfal, Rashad, Azar, William S., Eid, Assaad A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10054805/ https://www.ncbi.nlm.nih.gov/pubmed/36986825 http://dx.doi.org/10.3390/pharmaceutics15030965

Ejemplares similares

CYP450 Mediates Reactive Oxygen Species Production in a Mouse Model of β-Thalassemia through an Increase in 20-HETE Activity
por: Bou-Fakhredin, Rayan, et al.
Publicado: (2021)

Urinary 20-HETE: A prospective Non-Invasive prognostic and diagnostic marker for diabetic kidney disease
por: Houeiss, Pamela, et al.
Publicado: (2022)

Unraveling the Crosstalk between Lipids and NADPH Oxidases in Diabetic Kidney Disease
por: Njeim, Rachel, et al.
Publicado: (2023)

20-HETE and EETs in Diabetic Nephropathy: A Novel Mechanistic Pathway
por: Eid, Stephanie, et al.
Publicado: (2013)

COVID-19 and diabetes mellitus: how one pandemic worsens the other
por: Azar, William S., et al.
Publicado: (2020)

Influence of intermittent fasting on prediabetes-induced neuropathy: Insights on a novel mechanistic pathway
por: Dannawi, Maya, et al.
Publicado: (2022)

Dapagliflozin, SGLT2 Inhibitor, Attenuates Renal Ischemia-Reperfusion Injury
por: Chang, Yoon-Kyung, et al.
Publicado: (2016)

Effects of the SGLT‐2 inhibitor dapagliflozin on glomerular and tubular injury markers
por: Dekkers, Claire C. J., et al.
Publicado: (2018)

Reno-Protective Effect of GLP-1 Receptor Agonists in Type1 Diabetes: Dual Action on TRPC6 and NADPH Oxidases
por: Youssef, Natalie, et al.
Publicado: (2021)

Correction: Dapagliflozin, SGLT2 Inhibitor, Attenuates Renal Ischemia-Reperfusion Injury
por: Chang, Yoon-Kyung, et al.
Publicado: (2016)

A randomised study of the impact of the SGLT2 inhibitor dapagliflozin on microvascular and macrovascular circulation
por: Ott, Christian, et al.
Publicado: (2017)

Conflicting Roles of 20-HETE in Hypertension and Stroke
por: Shekhar, Shashank, et al.
Publicado: (2019)

Wearable flexible body matched electromagnetic sensors for personalized non-invasive glucose monitoring
por: Hanna, Jessica, et al.
Publicado: (2022)

SGLT-2-inhibition with dapagliflozin reduces tissue sodium content: a randomised controlled trial
por: Karg, M. V., et al.
Publicado: (2018)

SGLT2 inhibitor dapagliflozin prevents atherosclerotic and cardiac complications in experimental type 1 diabetes
por: Hodrea, Judit, et al.
Publicado: (2022)

SGLT2 inhibitor therapy for transthyretin amyloid cardiomyopathy: early tolerance and clinical response to dapagliflozin
por: Dobner, Stephan, et al.
Publicado: (2022)

Impacts of the DPP-4 Inhibitor Saxagliptin and SGLT-2 Inhibitor Dapagliflozin on the Gonads of Diabetic Mice
por: Alshamrani, Ali A., et al.
Publicado: (2023)

Effect of Chronically Suppressed Plasma Angiotensin II on Regulation of the CYP4A/20-HETE Pathway in the Dahl Salt-Sensitive Rat
por: Lukaszewicz, Kathleen, et al.
Publicado: (2023)

Efficacy and safety of dapagliflozin, a sodium glucose cotransporter 2 (SGLT2) inhibitor, in diabetes mellitus
por: Fioretto, Paola, et al.
Publicado: (2015)

The SGLT-2 Inhibitor Dapagliflozin Has a Therapeutic Effect on Atherosclerosis in Diabetic ApoE(−/−) Mice
por: Leng, Weiling, et al.
Publicado: (2016)

Dapagliflozin Activates Neurons in the Central Nervous System and Regulates Cardiovascular Activity by Inhibiting SGLT-2 in Mice
por: Nguyen, Thiquynhnga, et al.
Publicado: (2020)

The SGLT2 inhibitor dapagliflozin in heart failure with preserved ejection fraction: a multicenter randomized trial
por: Nassif, Michael E., et al.
Publicado: (2021)

The Effect of SGLT2 Inhibitor Dapagliflozin on Serum Levels of Apelin in T2DM Patients with Heart Failure
por: Berezin, Alexander A., et al.
Publicado: (2022)

Effects of SGLT2 inhibitor dapagliflozin in patients with type 2 diabetes on skeletal muscle cellular metabolism
por: op den Kamp, Yvo J.M., et al.
Publicado: (2022)

Resveratrol attenuates angiotensin II-induced cellular hypertrophy through the inhibition of CYP1B1 and the cardiotoxic mid-chain HETE metabolites
por: Shoieb, Sherif M., et al.
Publicado: (2020)

Cancer cell-derived 12(S)-HETE signals via 12-HETE receptor, RHO, ROCK and MLC2 to induce lymph endothelial barrier breaching
por: Nguyen, Chi Huu, et al.
Publicado: (2016)

Utility of 15(S)-HETE as a Serological Marker for Eosinophilic Esophagitis
por: Lu, Shaolei, et al.
Publicado: (2018)

Pseudomonas aeruginosa cytochrome P450 CYP168A1 is a fatty acid hydroxylase that metabolizes arachidonic acid to the vasodilator 19-HETE
por: Tooker, Brian C., et al.
Publicado: (2022)

Highly selective SGLT2 inhibitor dapagliflozin reduces seizure activity in pentylenetetrazol-induced murine model of epilepsy
por: Erdogan, Mumin Alper, et al.
Publicado: (2018)

The extracellular volume status predicts body fluid response to SGLT2 inhibitor dapagliflozin in diabetic kidney disease
por: Ohara, Ken, et al.
Publicado: (2020)

The SGLT2 inhibitor dapagliflozin promotes systemic FFA mobilization, enhances hepatic β-oxidation, and induces ketosis
por: Wallenius, Kristina, et al.
Publicado: (2022)

Exercise Augments the Effect of SGLT2 Inhibitor Dapagliflozin on Experimentally Induced Diabetic Cardiomyopathy, Possible Underlying Mechanisms
por: Eldesoqui, Mamdouh, et al.
Publicado: (2022)

Effect of SGLT-2 inhibitor, dapagliflozin, on left ventricular remodeling in patients with type 2 diabetes and HFrEF
por: Fu, Qianyu, et al.
Publicado: (2023)

Theoretical model for neurovascular coupling via interactions of NO, EET, and 20-HETE
por: Kang, Hyuk, et al.
Publicado: (2013)

Aspirin inhibits the production of proangiogenic 15(S)-HETE by platelet cyclooxygenase-1
por: Rauzi, Francesca, et al.
Publicado: (2016)

Analysis of HETEs in human whole blood by chiral UHPLC-ECAPCI/HRMS
por: Mazaleuskaya, Liudmila L., et al.
Publicado: (2018)

20-HETE Enzymes and Receptors in the Neurovascular Unit: Implications in Cerebrovascular Disease
por: Gonzalez-Fernandez, Ezekiel, et al.
Publicado: (2020)

Neonatal imprinting of alveolar macrophages via neutrophil-derived 12-HETE
por: Pernet, Erwan, et al.
Publicado: (2023)

Effect of the SGLT2 Inhibitor Dapagliflozin on Potassium Levels in Patients with Type 2 Diabetes Mellitus: A Pooled Analysis
por: Yavin, Yshai, et al.
Publicado: (2016)

Dapagliflozin Prevents NOX- and SGLT2-Dependent Oxidative Stress in Lens Cells Exposed to Fructose-Induced Diabetes Mellitus
por: Chen, Ying-Ying, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_9jibv265nhdephcgk6b4ng6l16